C61D07.5

Prostate Cancer

Malignant neoplasm of the prostate gland, the most common cancer in men.

Often asymptomaticUrinary frequencyHesitancyNocturiaHematuriaBone pain if metastatic

Key Documentation Elements

  • Gleason score and Grade Group
  • PSA level and trend
  • Clinical stage (TNM)
  • Risk stratification (low, intermediate, high)
  • Treatment modality and response
  • Active surveillance protocol compliance if applicable

Documentation Challenges

  • Documenting Gleason score and Grade Group
  • Recording PSA trends and kinetics
  • Capturing risk stratification for treatment planning
  • Tracking active surveillance compliance vs treatment

Billing Considerations

  • C61 for invasive vs D07.5 for in situ prostate carcinoma
  • Active surveillance vs active treatment documentation
  • PSA monitoring billing
  • Bone scan and imaging justification for staging

Frequently Asked Questions

What documentation is essential for prostate cancer?

Key elements include Gleason score, Grade Group, PSA trend, clinical stage, and risk stratification. Scribeable captures these from your clinical discussion and generates properly coded oncology documentation.

How does Scribeable help with prostate cancer management?

Scribeable documents Gleason scores, PSA kinetics, staging, and treatment plans from your encounter, supporting both active surveillance protocols and treatment documentation with correct coding.

Automate Prostate Ca Documentation

Scribeable captures all required elements for Prostate Ca from your patient conversation. AI-assisted ICD-10 coding and HCC capture.

ICD-10 Codes

C61D07.5

Prostate Cancer Documentation Guide

Malignant neoplasm of the prostate gland, the most common cancer in men.

ICD-10 Codes: C61, D07.5

Common Symptoms

  • Often asymptomatic
  • Urinary frequency
  • Hesitancy
  • Nocturia
  • Hematuria
  • Bone pain if metastatic

Key Documentation Elements

  • Gleason score and Grade Group
  • PSA level and trend
  • Clinical stage (TNM)
  • Risk stratification (low, intermediate, high)
  • Treatment modality and response
  • Active surveillance protocol compliance if applicable

Documentation Challenges

  • Documenting Gleason score and Grade Group
  • Recording PSA trends and kinetics
  • Capturing risk stratification for treatment planning
  • Tracking active surveillance compliance vs treatment

Billing Considerations

  • C61 for invasive vs D07.5 for in situ prostate carcinoma
  • Active surveillance vs active treatment documentation
  • PSA monitoring billing
  • Bone scan and imaging justification for staging

Frequently Asked Questions

What documentation is essential for prostate cancer?

Key elements include Gleason score, Grade Group, PSA trend, clinical stage, and risk stratification. Scribeable captures these from your clinical discussion and generates properly coded oncology documentation.

How does Scribeable help with prostate cancer management?

Scribeable documents Gleason scores, PSA kinetics, staging, and treatment plans from your encounter, supporting both active surveillance protocols and treatment documentation with correct coding.

Related Conditions